Back to Results
First PageMeta Content
Pharmaceutical sciences / Pharmaceutical industry / Pharmacology / Medical statistics / Interventional cardiology / Clinical trial / Clinical endpoint / Investigational Device Exemption / Data monitoring committees / Clinical research / Research / Medicine


LUTONIX® DRUG COATED BALLOON PTA CATHETER PMA P130024 FOR TREATMENT OF STENOTIC OR OBSTRUCTIVE LESIONS IN THE FEMOROPOPLITEAL ARTERY
Add to Reading List

Open Document

File Size: 1,75 MB

Share Result on Facebook

City

New Hope / /

Company

LIST OF ACRONYMS ABI ACC/AHA AE / LEVANT 2 Subgroup / C.R. Bard Inc. / Patient Subgroup / Lutonix Inc. / ITT / /

Country

United States / /

Currency

pence / /

Facility

American College / Duplex Ultrasound Ethics Committee Electronic Case Report Form Euro-Qol / /

IndustryTerm

Treatment of Peripheral Artery Disease / /

MedicalCondition

Peripheral Artery Disease / /

Organization

FDA / SFA / American College of Cardiology/American Heart Association Adverse Event Amputation Free Survival Active Pharmaceutical Ingredient American Standard Test Method Bare Metal Stent Clinical Events Committee Confidence Interval Critical Limb Ischemia / European Union / Clinical Events Committee / /

Person

Rutherford Grade / VIVA WIQ / SAE SAP SC SFA / /

Position

THE FEMOROPOPLITEAL ARTERY SPONSOR EXECUTIVE / /

Product

Paclitaxel / /

ProgrammingLanguage

EC / /

ProvinceOrState

Minnesota / /

PublishedMedium

Baseline / /

Region

LEVANT / /

Technology

Ultrasound / DUS / x-ray / API / /

SocialTag